AI-Driven Personalized Cognitive Behavioral Therapy Delivery via Dynamic Emotion-Adaptive Biofeedback
dev.to·20h·
Discuss: DEV
🧠NEUROCHEMISTRY
Drosophila melanogaster as a model to study negative symptoms of schizophrenia
frontiersin.org·11h·
Discuss: Hacker News
🧠NEUROCHEMISTRY
Statins Don’t Boost Mood: Major Study Debunks Antidepressant Claims
scitechdaily.com·13h
🧠NEUROCHEMISTRY
Lithium and Alzheimer’s Disease
theness.com·22h
🧠NEUROCHEMISTRY
Glymphatic system dysfunction correlated with gut dysbiosis and cognitive impairment in schizophrenia
nature.com·11h
🧠NEUROCHEMISTRY
Is Hallucinogen Dependendence or Use Disorder Real?
psychologytoday.com·15h
🍄PSYCHEDELICS
Epigenetic Memory Erasure via Targeted DNA Demethylation in Chronic Stress-Induced Hippocampal Neurogenesis Suppression
dev.to·1d·
Discuss: DEV
🧠NEUROCHEMISTRY
New schizophrenia drug improves symptoms current drugs can’t touch
newatlas.com·1d
🧠NEUROCHEMISTRY
STAT+: Pharmalittle: We’re reading about a Trump Jr. company, a GLP-1 health risk, and much more
statnews.com·21h
🧪Medicinal Chemistry
Lessons learned: Sharing stories about personal values builds trust and interest in science
hsph.harvard.edu·14h
🧠NEUROCHEMISTRY
Paper Review: TRImodal Brain Encoder
lesswrong.com·3h
🧠NEUROCHEMISTRY
The Fake ‘Mental Health’ Test Coming To Your Child’s School
dailywire.com·1d
🧠NEUROCHEMISTRY
Scientists discover how the brain makes new memories without erasing old ones
earth.com·21h
🧠NEUROCHEMISTRY
Research Psychiatrist Warns He’s Seeing a Wave of AI Psychosis
futurism.com·14h
🍄PSYCHEDELICS
The Random Show — Ketones for Cognition, Tim’s Best Lab Results in 10+ Years, How Kevin Hit 100 Days Sober, Home Defense, Vibe Coding Unleashed, and More (#822)
tim.blog·7h
🧠NEUROCHEMISTRY
Is laughter a form of therapeutic medicine?
medicalxpress.com·1d
🧠NEUROCHEMISTRY
When Gut Rhythms Over-Sync With the Brain, Mental Strain Rises
neurosciencenews.com·15h
🧠NEUROCHEMISTRY
Promising Blood Test For Chronic Fatigue Syndrome Could Be On Horizon
studyfinds.org·16h
🧠NEUROCHEMISTRY
Eli Lilly (LLY) Announced Positive Results From its Phase 3 ATTAIN-1 Trial of Orforglipron
finance.yahoo.com·12h
🧪Medicinal Chemistry
Researchers re-engineer AI language model to target previously 'undruggable' disease proteins
phys.org·2h
🧠NEUROCHEMISTRY